Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT01570387

A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis

Sponsor: Boston Medical Center

Interventions Dexamethasone Pomalidomide

Updated 11 times since 2017 Last updated: Sep 3, 2020 Started: Jun 30, 2012 Primary completion: Nov 30, 2018 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on AL Amyloidosis, this trial is completed. The trial is conducted by Boston Medical Center and has accumulated 11 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Oct 2020 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Active Not Recruiting → Completed
Aug 2020 — Oct 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2

▶ Show 6 earlier versions

Jan 2020 — Aug 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2
Feb 2019 — Jan 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2
Jun 2018 — Feb 2019 [monthly]

Active Not Recruiting PHASE1_PHASE2
May 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE1_PHASE2
Feb 2017 — May 2018 [monthly]

Active Not Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Medical Center
Celgene Corporation

Data source: Boston Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States